Gene amplification technology plays a vital role in the diagnostics field. With increasing aging population, countries worldwide face the challenge of preventing age-related diseases such as cardiovascular diseases and diabetes. This indicates the requirement of new diagnostics including genetic testing which make use of gene amplification technology. With the growing improvements in the diagnostic market, the DNA diagnostic technologies are set to achieve superior efficiencies and improved activity in numerous application areas, including healthcare, biomedical research, toxicology, bioremediation, forensics and personnel identification, environmental monitoring, quality control in the food industry, and agriculture.
Leading players profiled in the report include Bio Merieux, Bio-Rad Laboratories Cepheid, Roche Diagnostics, Rubicon Genomics, and Takara Bio.
The report titled "Gene Amplification Technologies: A Global Strategic Business Report" published by Global Industry Analysts, Inc., analyzes the market across the US, Canada, Japan, Europe, and Rest of World. Product segments analyzed in the report include PCR and Other Gene Amplification Technologies. The report enumerates recent developments, mergers, acquisitions and other strategic industry activities. Analysis is provided in US$ Million for the period 2000-2015.
For more details about this research report, please visit http://www.strategyr.com/Gene_Amplification_Technologies_Market_Report.asp
Copyright©2008 Vocus, Inc.
All rights reserved